Prognostic implication of EGFR gene mutations and histological classification in patients with resected stage I lung adenocarcinoma

Abstract

Low grade tumors according to IASLC/ATS/ERS histological classification and the pathologic stage IA tumors of resected stage I lung adenocarcinomas independently predict better DFS and OS. EGFR mutations were frequently seen in histologically low- and intermediate-grade tumors but not a prognostic factor.